PTPN13/IGF2BP1/c-Myc signaling pathway subsequently can enhance glutamine metabolism, resulting in increased glutathione levels and the glutathione/glutathione disulfide ratio in HCC cells.103. The gene discussed is MYC; the disease is hepatocellular carcinoma.